Discontinuation report DOXORUBICIN HYDROCHLORIDE INJECTION

Last updated on 2019-01-02 History
Report ID 59179
Drug Identification Number 02375710
Brand name DOXORUBICIN HYDROCHLORIDE INJECTION
Common or Proper name DOXORUBICIN
Company Name SANDOZ CANADA INCORPORATED
Active Ingredient(s) DOXORUBICIN HYDROCHLORIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVESICAL
Packaging size 25ML VIAL
ATC code L01DB
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for discontinuation Raw material availability
Anticipated discontinuation date
Actual discontinuation date 2019-01-01
Remaining supply date 2019-01-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-01-02 English Compare
v2 2018-08-27 French Compare
v1 2018-08-27 English Compare